Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 5/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.53 |
| ▸ | DRD3 | P35462 | 3/20 | 0.53 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | SCN1A | P35498 | 3/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.51 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2205198 | 0.90 | CHRM3 (0.51) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL2984162 | 0.89 | CHRM3 (0.56) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| Hydrochloric Acid SCHEMBL30448099 | 0.87 | CHRM3 (0.55) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL18994329 | 0.86 | OPRM1 (0.69) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL7643094 | 0.86 | CHRM3 (0.54) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL18248596 | 0.86 | CHRM3 (0.54) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL18248486 | 0.86 | CHRM3 (0.54) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| Methane SCHEMBL5604947 | 0.85 | OPRM1 (0.67) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL1614867 | 0.84 | CYP2C19 (0.54) | CHRM3LMNACYP2D6CHRM2KCNH2 | |
| SCHEMBL4030430 | 0.84 | MAPT (0.55) | CHRM3LMNACYP2D6CHRM2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112574056-B | Synthetic method of alpha, alpha-difluoro-gamma-hydroxyacetamide derivative | 浙江工业大学 | 2022-11-04 | — | — | CN | disclosed |
| CN-112574056-A | Synthetic method of alpha, alpha-difluoro-gamma-hydroxyacetamide derivative | 浙江工业大学 | 2021-03-30 | — | — | CN | disclosed |
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2012-10-18 | — | — | US | disclosed |
| US-5288905-A | Glycyl urea derivatives as anti-convulsants | G. D. SEARLE & CO. (US) | 1994-02-22 | — | — | US | disclosed |
| US-5278191-A | Nervous system disorders | G. D. SEARLE & CO. (US) | 1994-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264605-A1 | Multi-Functional Ionic Liquid Compositions for Overcoming Polymorphism and Imparting Improved Properties for Active Pharmaceutical, Biological, Nutritional, and Energetic Ingredients | SLC5A6, PNLIP, IPMK | CHRM3 2400/4885LMNA 1556/4885CYP2D6 453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.